Go or no go? Valuable drugs set for FDA decisions

Go or no go? Valuable drugs set for FDA decisions

Submitted by admin on July 29, 2020 - 10:54am
Source: 
EP Vantage
News Tags: 
FDA
drug approvals
Novartis
inclisiran
Biomarin
valrox
Roche
risdiplam
GSK
belantamab mafodotin
Gilead Sciences
Galapagos
filgotinib
Headline: 
Go or no go? Valuable drugs set for FDA decisions
snippet: 

Upcoming US approval verdicts include inclisiran, valrox and risdiplam, but toxicity issues could scupper filgotinib.

Do Not Allow Advertisers to Use My Personal information